DS
ALPN

DRW Securities’s Alpine Immune Sciences Inc ALPN Stock Holding History

DRW Securities’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,000
Closed -$38K – 393
2019
Q4 		$38K Hold
10,000
– – ﹤0.01% 224
2019
Q3 		$40K Hold
10,000
– – ﹤0.01% 134
2019
Q2 		$42K Hold
10,000
– – ﹤0.01% 114
2019
Q1 		$69K Sell
10,000
-18,700
-65% -$117K ﹤0.01% 78
2018
Q4 		$106K Hold
28,700
– – 0.01% 61
2018
Q3 		$182K Buy
28,700
+4,357
+18% +$30.5K 0.01% 41
2018
Q2 		$184K Buy
24,343
+14,143
+139% +$117K 0.01% 73
2018
Q1 		$82K Buy
+10,200
New +$101K 0.01% 152

Other funds holding ALPN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DRW Securities's ALPN Position: Q1 2020 in Review

DRW Securities sold out of Alpine Immune Sciences Inc (ALPN) in Q1 2020, closing a stake of 10,000 shares — an estimated $38K sold.

DRW Securities first reported a position in ALPN in Q1 2018 and held it in 8 quarters. The position peaked at $184K in Q2 2018. 17 funds tracked by Wall St. Rank hold ALPN as of Q1 2020.

  • DRW Securities reported no remaining Alpine Immune Sciences Inc position as of Q1 2020 after selling out during the quarter.
  • DRW Securities sold 10,000 Alpine Immune Sciences Inc shares in Q1 2020, an estimated $38K.
  • DRW Securities first reported a position in Alpine Immune Sciences Inc in Q1 2018 and held it in 8 quarters.
  • DRW Securities's Alpine Immune Sciences Inc position peaked at $184K in Q2 2018.
  • 17 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q1 2020.

Based on DRW Securities's 13F filing for Q1 2020, filed 13 May 2020.